News|Articles|May 15, 2014

EMA Opens Registration for European Network of Paediatric Research Workshop

EMA opens registration for it's sixth annual workshop on pediatric drug research and development.

The European Medicines Agency (EMA) has begun registration for its sixth workshop of the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA). The workshop will take place at EMA’s headquarters in London on June 26-27, 2014. The workshop, which aims to strengthen communication between stakeholders, will update participants from all aspects of the industry on “Enpr-EMA’s efforts to foster high-quality paediatric drug research and to contribute to the ongoing development of research and clinical trials in the area of paediatric medicine.”

Enpr-EMA, which is comprised by a network of research networks, investigators, and centers with expertise in performing clinical studies in children, fosters ethical research on the quality, safety and efficacy of medicines for use in children; helps recruit patients for clinical trials, and creates collaboration between networks.

Workshop registration forms can be found on EMA’s website) and should be submitted to enprema@ema.europa.eu.


Related to this article

Regulatory Roundup—September 2026
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Pharma Logistician Using IoT Based On Blockchain | Image Credit: ©leowolfert -stock.adobe.com
Michael Levy, senior vice president, Digital & Innovation, USP, explains the digital supply chain in a preview of his upcoming CPHI Milan panel presentation, The Next Phase of Pharma Supply Chains.